UPDATE: Bellerophon Therapeutics (BLPH) PT Lowered to $19 at Brookline Capital Markets
Tweet Send to a Friend
(Updated - April 4, 2022 12:29 PM EDT)
Brookline Capital Markets analyst Kemp Dolliver lowered the price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Brookline Capital Markets analyst Kemp Dolliver lowered the price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
